Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.97 billion. The enterprise value is $1.76 billion.
| Market Cap | 1.97B |
| Enterprise Value | 1.76B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 76.73 million shares outstanding. The number of shares has decreased by -4.01% in one year.
| Current Share Class | 76.73M |
| Shares Outstanding | 76.73M |
| Shares Change (YoY) | -4.01% |
| Shares Change (QoQ) | -3.08% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 103.62% |
| Float | 70.15M |
Valuation Ratios
The trailing PE ratio is 28.33 and the forward PE ratio is 11.83. Progyny's PEG ratio is 1.02.
| PE Ratio | 28.33 |
| Forward PE | 11.83 |
| PS Ratio | 1.51 |
| Forward PS | 1.38 |
| PB Ratio | 4.35 |
| P/TBV Ratio | 4.63 |
| P/FCF Ratio | 11.11 |
| P/OCF Ratio | 9.84 |
| PEG Ratio | 1.02 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.07, with an EV/FCF ratio of 9.90.
| EV / Earnings | 22.47 |
| EV / Sales | 1.35 |
| EV / EBITDA | 14.07 |
| EV / EBIT | 14.74 |
| EV / FCF | 9.90 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.14 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | 0.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.24% and return on invested capital (ROIC) is 32.74%.
| Return on Equity (ROE) | 16.24% |
| Return on Assets (ROA) | 10.14% |
| Return on Invested Capital (ROIC) | 32.74% |
| Return on Capital Employed (ROCE) | 25.19% |
| Weighted Average Cost of Capital (WACC) | 9.73% |
| Revenue Per Employee | $1.53M |
| Profits Per Employee | $91,861 |
| Employee Count | 856 |
| Asset Turnover | 1.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $41.21 million in taxes.
| Income Tax | 41.21M |
| Effective Tax Rate | 34.38% |
Stock Price Statistics
The stock price has increased by +8.58% in the last 52 weeks. The beta is 1.02, so Progyny's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +8.58% |
| 50-Day Moving Average | 29.06 |
| 200-Day Moving Average | 23.88 |
| Relative Strength Index (RSI) | 32.84 |
| Average Volume (20 Days) | 1,100,465 |
Short Selling Information
The latest short interest is 4.49 million, so 5.85% of the outstanding shares have been sold short.
| Short Interest | 4.49M |
| Short Previous Month | 4.63M |
| Short % of Shares Out | 5.85% |
| Short % of Float | 6.39% |
| Short Ratio (days to cover) | 3.98 |
Income Statement
In the last 12 months, Progyny had revenue of $1.31 billion and earned $78.63 million in profits. Earnings per share was $0.91.
| Revenue | 1.31B |
| Gross Profit | 322.09M |
| Operating Income | 119.83M |
| Pretax Income | 119.84M |
| Net Income | 78.63M |
| EBITDA | 125.57M |
| EBIT | 119.83M |
| Earnings Per Share (EPS) | $0.91 |
Balance Sheet
The company has $236.93 million in cash and $22.50 million in debt, with a net cash position of $214.43 million or $2.79 per share.
| Cash & Cash Equivalents | 236.93M |
| Total Debt | 22.50M |
| Net Cash | 214.43M |
| Net Cash Per Share | $2.79 |
| Equity (Book Value) | 453.26M |
| Book Value Per Share | 5.90 |
| Working Capital | 272.93M |
Cash Flow
In the last 12 months, operating cash flow was $201.25 million and capital expenditures -$22.86 million, giving a free cash flow of $178.38 million.
| Operating Cash Flow | 201.25M |
| Capital Expenditures | -22.86M |
| Depreciation & Amortization | 5.74M |
| Net Borrowing | n/a |
| Free Cash Flow | 178.38M |
| FCF Per Share | $2.32 |
Margins
Gross margin is 24.57%, with operating and profit margins of 9.14% and 6.00%.
| Gross Margin | 24.57% |
| Operating Margin | 9.14% |
| Pretax Margin | 9.14% |
| Profit Margin | 6.00% |
| EBITDA Margin | 9.58% |
| EBIT Margin | 9.14% |
| FCF Margin | 13.61% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.01% |
| Shareholder Yield | 4.01% |
| Earnings Yield | 3.97% |
| FCF Yield | 9.00% |
Analyst Forecast
The average price target for Progyny is $33.73, which is 31.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.73 |
| Price Target Difference | 31.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 7.57% |
| EPS Growth Forecast (3Y) | 8.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 7.63 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.63 |
| Piotroski F-Score | 6 |